Company / Assets per Share
RIGEL PHARMACEUTICALS INC Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$29.00
FY2025
5-year range
$0.68 / $29.00
FY2021-FY2025
Trend
+209.2%
vs FY2024
Sector context
#41 of 210
Health Care
What the data says
Assets per Share changed +209% YoY in FY2025, a notable deviation from the 9-year average annual change of +166%.
Based on SEC 10-K filings.
29.00 in FY2025 with a 5-year CAGR of +113.3%. Top quartile in the Health Care sector.
Improved from $0.68 to $29.00 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +233.4%
- 5-Year CAGR
- +113.3%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 210This company $29.00 Sector average $296.79
▼
-90.2% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 209.2% year-over-year.
- Ranks #41 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.00 | +209.2% |
| FY2024 | $9.38 | +1287.4% |
| FY2023 | $0.68 | -13.6% |
| FY2022 | $0.78 | -20.8% |
| FY2021 | $0.99 | +50.4% |
| FY2020 | $0.66 | -25.6% |
| FY2019 | $0.88 | -6.8% |
| FY2018 | $0.95 | +0.5% |
| FY2017 | $0.94 | +13.9% |
| FY2016 | $0.83 | -44.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026